|
|
||||||||



,
* Cell Biology and Genetics Program,
Biochemistry and Structural Biology Program, and
Immunology Program, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021; and
Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Immunology Program, New York, NY 10021
In the endosomes of APCs, the MHC class II-like molecule H2-M catalyzes the exchange of class II-associated invariant chain peptides (CLIP) for antigenic peptides. H2-O is another class II-like molecule that modulates the peptide exchange activity of H2-M. Although the expression pattern of H2-O in mice has not been fully evaluated, H2-O is expressed by thymic epithelial cells, B cells, and dendritic cells (DCs). In this study, we investigated H2-O, H2-M, and I-Ab-CLIP expression patterns in B cell subsets during B cell development and activation. H2-O was first detected in the transitional 1 B cell subset and high levels were maintained in marginal zone and follicular B cells. H2-O levels were down-regulated specifically in germinal center B cells. Unexpectedly, we found that mouse B cells may have a pool of H2-O that is not associated with H2-M. Additionally, we further evaluate H2-O and H2-M interactions in mouse DCs, as well as H2-O expression in bone marrow-derived DCs. We also evaluated H2-O, H2-M, I-Ab, and I-Ab-CLIP expression in splenic DC subsets, in which H2-O expression levels varied among the splenic DC subsets. Although it has previously been shown that H2-O modifies the peptide repertoire, H2-O expression did not alter DC presentation of a number of endogenous and exogenous Ags. Our further characterization of H2-O expression in DCs, as well as the identification of a potential free pool of H2-O in mouse splenic B cells, suggest that H2-O may have a yet to be elucidated role in immune responses.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Public Health Service Grants AI46202 and AI61484 (to L.K.D.) and P30-CA08748 (to Memorial Sloan-Kettering Cancer Center).
2 Address correspondence and reprint requests to Dr. Lisa K. Denzin, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, Box 509, New York, NY 10021. E-mail address: denzinl{at}mskcc.org
3 Abbreviations used in this paper: ER, endoplasmic reticulum; I, invariant; MIIC, MHC class II compartment; CLIP, class II-associated invariant chain peptide; DC, dendritic cell; FO, follicular; MZ, marginal zone; GC, germinal center; sDC, splenic DC; bmDC, bone marrow-derived DC; NP, (4-hydroxy-3-nitrophenyl)acetyl; CGG, chicken
globulin; IP, immunoprecipitation; PVDF, polyvinylidene difluoride;
2m,
2-microglobulin; HEL, hen egg lysozyme; SIGN, specific ICAM-3-grabbing nonintegrin; MFI, mean fluorescence intensity; KO, knockout.
This article has been cited by other articles:
![]() |
C. H. Rinderknecht, M. P. Belmares, T. L. W. Catanzarite, A. J. Bankovich, T. H. Holmes, K. C. Garcia, N. K. Nanda, R. Busch, S. Kovats, and E. D. Mellins Posttranslational Regulation of I-Ed by Affinity for CLIP J. Immunol., November 1, 2007; 179(9): 5907 - 5915. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |